Penka Petrova

Chief Development Officer at Trillium Therapeutics Inc. - Mississauga, ON, CA

Penka Petrova's Contact Details
HQ
857-412-7029
Location
Company
Trillium Therapeutics Inc.
Penka Petrova's Company Details
Trillium Therapeutics Inc. logo, Trillium Therapeutics Inc. contact details

Trillium Therapeutics Inc.

Mississauga, ON, CA • 50 - 99 Employees
BioTech/Drugs

Trillium Therapeutics Inc. (NASDAQ/TSX:TRIL) is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. We have a strong focus on CD47, a molecule that tumors frequently use to evade the immune system. CD47 is a protective "do not eat" signal that blocks the ability of certain immune cells to destroy the tumor. By blocking this "do not eat" signal with decoy receptors, we aim to unmask tumor cells and make them visible to, and eradicated by, the immune system.

Biotechnology Healthcare Pharmaceuticals
Details about Trillium Therapeutics Inc.
Frequently Asked Questions about Penka Petrova
Penka Petrova currently works for Trillium Therapeutics Inc..
Penka Petrova's role at Trillium Therapeutics Inc. is Chief Development Officer.
Penka Petrova's email address is ***@trilliumtherapeutics.com. To view Penka Petrova's full email address, please signup to ConnectPlex.
Penka Petrova works in the Biotechnology industry.
Penka Petrova's colleagues at Trillium Therapeutics Inc. are Vivette Ritchie, Tina Kirkham, Vien Chai, Krystyna ACRP, Tran Truong, Mark Wong, William Yeung and others.
Penka Petrova's phone number is 857-412-7029
See more information about Penka Petrova